TGFB1 and cancer: The inhibitory effect of dasatinib on TGF-β1/ALK5-mediated cell motility corresponded well with the potency of this agent to inhibit various TGF-β1-regulated marker genes involved in EMT, migration/invasion, and a cancer stem cell phenotype.